The bill requires any abortion provider engaged in interstate or foreign commerce to perform an ultrasound, share its results with the patient, and obtain a signed, in‑person Informed Consent Authorization at least 24 hours before carrying out any part of an abortion (except in defined medical emergencies). The form must state the probable gestational age in completed days, list all medical risks associated with the method or drugs used, and describe “major developmental characteristics” of the unborn child (including heartbeat and responses to painful stimuli).
Providers must keep the signed form in the patient’s medical file and the bill incorporates a HIPAA record‑retention reference.
Enforcement is both federal and private: the Attorney General may bring civil actions that carry per‑violation fines ($100,000–$150,000 for a first adjudicated violation; $150,001–$250,000 for subsequent ones) and private plaintiffs (the woman or a parent of a minor) may sue for verifiable damages, treble statutory damages equal to three times the cost of the abortion, and punitive damages; fee shifting rules favor prevailing plaintiffs and permit fee awards against frivolous suits. The bill also contains a savings clause allowing states to keep or adopt more extensive disclosure and penalty regimes.
At a Glance
What It Does
Requires providers to perform an ultrasound, share the results, and present a statutorily specified in‑person consent form at least 24 hours before an abortion (unless a medical emergency exists). The form must identify gestational age in completed days, enumerate medical risks, and describe fetal developmental characteristics.
Who It Affects
Licensed clinicians who perform or induce abortions (including those who prescribe abortion‑inducing drugs and telemedicine prescribers whose practice affects interstate commerce), clinics and hospitals that provide abortion care, and plaintiffs’ attorneys and state medical licensing authorities who will receive notifications of federal enforcement actions.
Why It Matters
The bill federalizes detailed pre‑procedure disclosure requirements that currently vary across states and expressly reaches prescribing and telehealth conduct by defining 'perform' to include inducing an abortion through prescription. It couples document‑retention and civil enforcement mechanisms likely to change compliance workflows, clinical timing, and legal exposure for providers.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The statute compels abortion providers operating in or affecting interstate commerce to complete two core tasks before doing any part of an abortion: perform an ultrasound (using any method agreed between physician and patient) and present an in‑person, written Informed Consent Authorization at least 24 hours before the procedure. That form must be signed by the patient, the provider, and a witness, and must state the probable gestational age in completed days, the medical risks associated with the specific procedure or drugs, and the 'major developmental characteristics' of the unborn child at that gestational age — the bill explicitly lists heartbeat, ability to react to painful stimuli, and development of organs, appendages, and facial features.
The provider must retain the signed form in the patient’s medical record, and the bill cross‑references 45 C.F.R. §164.530(j)(2) to require the same data‑retention treatment as certain HIPAA documentation. The statute creates a narrow emergency exception: if, in a reasonably prudent provider’s medical judgment, complying with the ultrasound or consent timing would increase the risk of the patient’s death or cause substantial, irreversible physical impairment of a major bodily function, the provider may proceed without meeting those requirements.Enforcement has two parallel tracks.
The Attorney General may bring a civil action for violations and obtain per‑violation fines that escalate on repeat adjudications; the statute requires the Attorney General to notify the appropriate State medical licensing authority after an assessed penalty. Separately, the woman (or a parent of a minor) may sue the provider for 'appropriate relief' including objectively verifiable damages, statutory damages equal to three times the cost of the abortion, and punitive damages, with courts required to award prevailing plaintiffs reasonable attorneys’ fees and empowered to award defendants fees if the suit is frivolous.
The statute bars monetary penalties against the pregnant woman and disallows damages where the pregnancy resulted from the plaintiff’s criminal conduct.Key definitional choices extend the statute’s reach: 'perform' explicitly includes inducing an abortion via medical or chemical means (for example, prescribing a drug intended to cause abortion), and 'abortion provider' includes anyone licensed to practice medicine or otherwise legally authorized to perform an abortion. Those choices signal the bill’s application to medication abortion and telemedicine prescribing, and they raise practical questions about interstate prescribing, recordkeeping, and how clinics incorporate the 24‑hour, in‑person presentation requirement into telehealth and cross‑state care models.
The Five Things You Need to Know
The bill requires the provider to present the signed Informed Consent Authorization form in person at least 24 hours before performing or attempting any part of an abortion, with signatures from the patient, the provider, and a witness.
The consent form must state the probable gestational age in completed days and describe 'major developmental characteristics' at that age, specifically listing heartbeat, ability to react to painful stimuli, and development of organs, appendages, and facial features.
The statute defines 'perform' to include inducing an abortion through medical or chemical intervention (including prescribing), which brings medication‑abortion prescribers and telemedicine into the law’s scope where interstate commerce is implicated.
The Attorney General may seek civil penalties of $100,000–$150,000 per violation for a first adjudicated offense and $150,001–$250,000 for subsequent adjudicated violations; the AG must also notify state medical licensing boards after penalties are assessed.
A private right of action lets the woman or a parent of a minor sue for verifiable damages, punitive damages, and statutory damages equal to three times the cost of the abortion; prevailing plaintiffs recover attorneys’ fees, and defendants may recover fees only if the suit is frivolous.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Formal short title establishing the act as the 'Ultrasounds Save Lives Act of 2025.' This is a caption clause only; it does not affect substantive obligations or scope.
Ultrasound and in‑person consent form requirements
Sets the core compliance obligations: perform an ultrasound and share the results, and present an Informed Consent Authorization at least 24 hours before any part of the abortion is performed (unless the emergency exception applies). The bill allows the ultrasound method to be chosen by physician and patient, but requires in‑person presentation of the form by the abortion provider, not by delegated staff or remotely—this timing and in‑person mandate has practical consequences for telemedicine and multi‑state care models.
Content, signatories, retention, and HIPAA cross‑reference
Specifies four required elements of the form (gestational age in completed days; list of medical risks tied to the method or drugs used; 'major developmental characteristics' at that age; and statements about the provider’s obligations and potential civil/criminal penalties). The form must be signed by patient, provider, and witness and retained in the patient’s medical file. By tying paragraph (j)(2) of 45 C.F.R. §164.530 to these records, the bill requires the form to be handled for retention in the same manner as certain HIPAA documentation — a technical choice that invites questions about privacy, access, and retention timelines.
Medical‑emergency exception
Allows failure to meet the ultrasound and timing requirements where a reasonably prudent abortion provider judges that compliance would increase the risk of the patient’s death or cause substantial and irreversible physical impairment of a major bodily function. The clause excludes psychological or emotional conditions from qualifying, constraining the exception to acute physical threats and making the provider’s contemporaneous medical judgment central to invoking it.
Enforcement — federal civil penalties and notification
Authorizes the Attorney General to bring civil actions and permits courts to assess per‑violation monetary penalties that escalate for repeat adjudications. The statute fixes large minimum penalty floors and requires the AG to notify state medical licensing authorities after a penalty is assessed, thereby coupling federal monetary relief with state professional discipline channels.
Private right of action and fee shifting
Creates a private cause of action for the woman (or a parent of a minor) to recover objectively verifiable damages, statutory treble damages equal to three times the abortion’s cost, and punitive damages. Courts must award reasonable attorneys’ fees to prevailing plaintiffs but may award fees to prevailing defendants only if the plaintiff’s suit was frivolous. The bill bars monetary relief against the pregnant woman and disallows damages where the pregnancy resulted from the plaintiff’s criminal conduct.
Preemption, rule of construction, and definitions
Preserves state laws that are 'more extensive' than the federal requirements, allows the disclosure to be given at the same time as acquiring state‑law informed consent as long as it occurs 24 hours before the abortion, and sets definitions (including 'abortion,' 'perform,' 'abortion provider,' 'unborn child,' and 'reasonable medical judgment') that materially shape reach — most notably, 'perform' includes inducing abortion through prescription and 'unborn child' is defined as beginning at fertilization.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Pregnant patients who seek detailed prenatal information — the law guarantees a standardized, written description of gestational age, procedural risks, and specified developmental characteristics before the decision to proceed.
- Parents of minors — the statute gives parents standing to bring civil suits on behalf of minors if the consent requirements are not followed.
- State licensing boards and regulators — the Attorney General’s obligation to notify state medical licensing authorities after federal penalties provides them with case referrals and factual records to pursue professional discipline where appropriate.
- Plaintiff attorneys and advocacy organizations that represent patients — the bill creates a federal private right of action with fee shifting for prevailing plaintiffs and statutory damages, increasing the potential client remedies and litigation leverage.
Who Bears the Cost
- Abortion providers (clinics, hospitals, and individual clinicians), including telemedicine prescribers — they must perform or document ultrasounds, present the in‑person form 24 hours before care, retain the record under HIPAA‑style rules, and face substantial civil fines and private exposure for noncompliance.
- Small clinics and rural providers — the in‑person and 24‑hour timing requirement may force additional visits, increase scheduling complexity, and raise costs for clinics that serve geographically dispersed patients.
- Healthcare systems and insurers — they may incur added costs from extra ultrasound imaging, administrative burdens for storing consent forms as HIPAA‑style records, and potential downstream litigation or indemnity claims.
- Department of Justice and state medical boards — the Attorney General’s civil enforcement role and mandatory notifications will demand investigative and prosecutorial resources and create intergovernmental coordination costs.
Key Issues
The Core Tension
The central dilemma is straightforward: the bill seeks to secure patient access to specific prenatal and risk information by compelling providers to deliver standardized, in‑person disclosures and by creating strong enforcement tools — but those same features constrain clinical discretion, complicate telehealth and medication‑abortion models, and create large civil and administrative liabilities that may reduce providers’ willingness or ability to deliver timely care.
The bill blends federal standardization with broad definitional choices that expand its practical reach, but it leaves several operational and legal friction points unresolved. Defining 'perform' to include inducing abortion via prescription brings medication abortion and out‑of‑state teleprescribing squarely into scope where interstate commerce is implicated; yet the statute simultaneously requires in‑person presentation of the consent form 24 hours before the abortion, creating an operational mismatch for telehealth workflows unless clinics arrange an in‑person visit.
The HIPAA cross‑reference makes record retention explicit, but it does not specify retention periods or access protocols for a document that also contains statutorily framed content assertions (gestational age in completed days and listed developmental features), raising privacy and medical‑accuracy disputes.
Enforcement design creates tension between centralized federal litigation and decentralized medical regulation. The Attorney General’s large per‑violation fines and mandatory notification to state medical boards amplify consequences for providers, but resource constraints and questions about proving 'knowing' violations will shape enforcement in practice.
The private right of action with treble statutory damages and mandatory fee awards for prevailing plaintiffs invites high‑stakes litigation, and the statute’s limited fee protection for defendants (only where suits are frivolous) may change litigation calculus and increase defensive behavior. Finally, the bill’s required language about 'major developmental characteristics' intersects with contested medical claims (e.g., about fetal pain or precise organogenesis timelines) and could prompt evidence disputes in both licensing and civil proceedings.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.